B&L expands offering

Article

Bausch & Lomb has announced a joint venture with femtosecond laser developer 20/10 Perfect Vision, which will allow B&L to offer surgeons the complete 'all laser' refractive solution.

Bausch & Lomb has announced a joint venture with femtosecond laser developer 20/10 Perfect Vision, which will allow B&L to offer surgeons the complete ‘all laser’ refractive solution.

The company also launched the Crystalens HD accommodating IOL and the Advanced Control Eye Tracking (ACE) technology for its Zyoptix refractive platform, which, according to B&L, compensates for static rotational movement and pupil shift for improved accuracy and predictability.

The Crystalens HD, the successor to the Crystalens Five-O, gained CE mark approval in August and was showcased to Europe for the first time at the congress. This initial launch will be followed by a full-scale rollout, expected in the second quarter of 2009.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.